Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,410 public trials 2,002 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, not recruiting

Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC

NCT04448886

Conditions
Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +7 more
Locations
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • DFCI @ Foxborough Foxborough, Massachusetts, United States
View Trial Details
Active, not recruiting

Cell-free DNA in Hereditary And High-Risk Malignancies 1

NCT04261972

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +33 more
Locations
  • BC Cancer Agency Vancouver, British Columbia, Canada
  • Eastern Health St. John's, Newfoundland and Labrador, Canada
  • IWK Health Centre Halifax, Nova Scotia, Canada
  • Sinai Health System Toronto, Ontario, Canada
View Trial Details
Active, not recruiting

Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer

NCT04906395

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Marin Cancer Care, Inc Greenbrae, California, United States
  • Cypress Hematology and Oncology Parker, Colorado, United States
  • Mount Sinai Hospital Chicago, Illinois, United States
  • Baptist Health Louisville Louisville, Kentucky, United States
View all 59 locations
View Trial Details
Active, not recruiting

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

NCT06234488

Conditions
Breast Adenocarcinoma, Breast Cancer, Breast Cancer Invasive, +14 more
Locations
  • University of Southern California/Los Angeles (USC/LA County) Los Angeles, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
  • University of Colorado Anschutz Medical Campus (CU Anschutz) Aurora, Colorado, United States
  • MedStar Georgetown University Hospital (MGUH) Washington D.C., District of Columbia, United States
View all 22 locations
View Trial Details
Active, not recruiting

A Study of Tucatinib (MK-7119) in Combination With Trastuzumab and Capecitabine in Participants With Previously Treated Locally Advanced Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Carcinoma (MK-7119-001)

NCT04721977

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Aichi Cancer Center Hospital ( Site 1013) Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital ( Site 1021) Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East ( Site 1002) Kashiwa, Chiba, Japan
  • National Hospital Organization Shikoku Cancer Center ( Site 1014) Matsuyama, Ehime, Japan
View all 28 locations
View Trial Details

Related conditions